Abstract is: Anna Lembke (born November 27, 1967) is an American psychiatrist who is Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic at Stanford University. She is a specialist in the opioid epidemic in the United States, and the author of Drug Dealer, MD, How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop. Her latest book, a New York Times bestseller, Dopamine Nation: Finding Balance in the Age of Indulgence, was released in August 2021. Lembke appeared in the 2020 Netflix documentary The Social Dilemma.
| human | Q5 |
| P9984 | CANTIC ID | 981060927758606706 |
| P3846 | DBC author ID | 870979136063073 |
| P6394 | ELNET ID | a12470491 |
| P227 | GND ID | 115431748X |
| P2671 | Google Knowledge Graph ID | /g/11dxqdcz1m |
| P269 | IdRef ID | 256235317 |
| P213 | ISNI | 0000000454511674 |
| P244 | Library of Congress authority ID | n2016012568 |
| P8189 | National Library of Israel J9U ID | 987007356675105171 |
| P5034 | National Library of Korea ID | KAC202205375 |
| P7699 | National Library of Lithuania ID | LNB:DGBR;=xs |
| P1006 | Nationale Thesaurus voor Auteursnamen ID | 434971219 |
| P349 | NDL Authority ID | 032462707 |
| P691 | NL CR AUT ID | xx0269553 |
| P1015 | NORAF ID | 1634286305247 |
| P1207 | NUKAT ID | n2023016079 |
| P496 | ORCID iD | 0000-0002-1352-487X |
| P7293 | PLWABN ID | 9810634097005606 |
| P1005 | Portuguese National Library author ID | 1866335 |
| P214 | VIAF ID | 1567145856897922920071 |
| 313526453 |
| P27 | country of citizenship | United States of America | Q30 |
| P101 | field of work | psychiatry | Q7867 |
| addictology | Q2362817 | ||
| P735 | given name | Anna | Q666578 |
| Anna | Q666578 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | psychiatrist | Q211346 |
| researcher | Q1650915 | ||
| P21 | sex or gender | female | Q6581072 |
| Q122116160 | Dopamin: jak přežít blahobyt a neubavit se k smrti |
| Q46062108 | A Day in the Life of an Academic Psychiatrist |
| Q73932546 | A Friday in the life of an academic psychiatrist |
| Q46154156 | A call to include people with mental illness and substance use disorders alongside 'regular' smokers in smoking cessation research |
| Q34288367 | A prospective trial of modafinil as an adjunctive treatment of major depression |
| Q36354153 | A qualitative study of treatment-seeking heroin users in contemporary China |
| Q30502578 | Alcohol screening scores and the risk of new-onset gastrointestinal illness or related hospitalization |
| Q36821112 | Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression |
| Q46479309 | Assessment of provider attitudes toward #naloxone on Twitter |
| Q91951762 | Buprenorphine Induction Without Opioid Withdrawal: A Case Series of 15 Opioid-Dependent Inpatients Induced on Buprenorphine Using Microdoses of Transdermal Buprenorphine |
| Q38259393 | Clinical management of alcohol use disorders in the neurology clinic |
| Q35757913 | Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: drugs and devices |
| Q24658121 | Depression and smoking cessation: does the evidence support psychiatric practice? |
| Q37730862 | Distribution of Opioids by Different Types of Medicare Prescribers |
| Q47960073 | Extended treatment for cigarette smoking cessation: a randomized control trial |
| Q45061559 | From self-medication to intoxication: time for a paradigm shift |
| Q51056018 | Impaired recognition of facial emotion in mania. |
| Q91034225 | Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment |
| Q44247108 | Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders |
| Q92109756 | Online mutual-help intervention for reducing heavy alcohol use |
| Q53450635 | Our Other Prescription Drug Problem. |
| Q49922633 | Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period. |
| Q91264897 | Patterns of Opioid and Benzodiazepine Use in Opioid-Naïve Patients with Newly Diagnosed Low Back and Lower Extremity Pain |
| Q90857184 | Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy |
| Q44737385 | Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers |
| Q48374025 | Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol. |
| Q37028407 | Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration |
| Q30954237 | Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program |
| Q36525578 | Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder. |
| Q57099544 | Qualitative Assessment of Clerkship Students' Perspectives of the Topics of Pain and Addiction in their Preclinical Curriculum |
| Q42409274 | Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification |
| Q48130275 | Recovery-oriented policy and care systems in the UK and USA. |
| Q92872330 | Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine |
| Q37063525 | Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence |
| Q36150550 | Risk of future trauma based on alcohol screening scores: a two-year prospective cohort study among US veterans |
| Q35194349 | Safety of antidepressants in the elderly |
| Q92898400 | Substance Use Among Older Adults: Ethical Issues |
| Q92370779 | Tapering Long-Term Opioid Therapy |
| Q95421474 | Tapering Patients Off of Benzodiazepines |
| Q52316426 | The Opioid Epidemic as a Watershed Moment for Physician Training in Addiction Medicine. |
| Q36787614 | The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. |
| Q46188488 | The relationships of positive and negative symptoms with neuropsychological functioning and their ability to predict verbal memory in psychotic major depression |
| Q38038232 | Time to abandon the self-medication hypothesis in patients with psychiatric disorders |
| Q100489605 | Unsafe Supply: Why Making Controlled Prescription Drugs Available for Unsupervised Use Will Not Target the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19-- A Commentary on Bonn et al. (2020) |
| Q34471515 | Update on augmentation of antidepressant response in resistant depression |
| Q42337050 | Use of Opioid Agonist Therapy for Medicare Patients in 2013. |
| Q44337994 | Weighing the Risks and Benefits of Chronic Opioid Therapy |
| Q44336522 | Why doctors prescribe opioids to known opioid abusers |
| Q44340636 | Why doctors prescribe opioids to known opioid abusers. How cultural attitudes and financial disincentives affect the prescribing habits of physicians |
| Q48501181 | Why is this special issue on women's professional development in psychiatry necessary? |
| Q109304042 | JRE #1708 - Anna Lembke | talk show guest | P5030 |
| Anna Lembke | wikipedia |
Search more.